198 related articles for article (PubMed ID: 7659478)
1. Description and evaluation of serologic assays used in a multicenter trial of acellular pertussis vaccines.
Meade BD; Deforest A; Edwards KM; Romani TA; Lynn F; O'Brien CH; Swartz CB; Reed GF; Deloria MA
Pediatrics; 1995 Sep; 96(3 Pt 2):570-5. PubMed ID: 7659478
[TBL] [Abstract][Full Text] [Related]
2. Relationships between functional assays and enzyme immunoassays as measurements of responses to acellular and whole-cell pertussis vaccines.
Meade BD; Lynn F; Reed GF; Mink CM; Romani TA; Deforest A; Deloria MA
Pediatrics; 1995 Sep; 96(3 Pt 2):595-600. PubMed ID: 7659484
[TBL] [Abstract][Full Text] [Related]
3. Comparison of 13 acellular pertussis vaccines: overview and serologic response.
Edwards KM; Meade BD; Decker MD; Reed GF; Rennels MB; Steinhoff MC; Anderson EL; Englund JA; Pichichero ME; Deloria MA
Pediatrics; 1995 Sep; 96(3 Pt 2):548-57. PubMed ID: 7659475
[TBL] [Abstract][Full Text] [Related]
4. A randomized comparison of reactogenicity and immunogenicity of two whole-cell pertussis vaccines.
Steinhoff MC; Reed GF; Decker MD; Edwards KM; Englund JA; Pichichero ME; Rennels MB; Anderson EL; Deloria MA; Meade BD
Pediatrics; 1995 Sep; 96(3 Pt 2):567-70. PubMed ID: 7659477
[TBL] [Abstract][Full Text] [Related]
5. Effect of gender, race, and parental education on immunogenicity and reported reactogenicity of acellular and whole-cell pertussis vaccines.
Christy C; Pichichero ME; Reed GF; Decker MD; Anderson EL; Rennels MB; Englund JA; Edwards KM; Steinhoff MC
Pediatrics; 1995 Sep; 96(3 Pt 2):584-7. PubMed ID: 7659481
[TBL] [Abstract][Full Text] [Related]
6. The effect of maternal antibody on the serologic response and the incidence of adverse reactions after primary immunization with acellular and whole-cell pertussis vaccines combined with diphtheria and tetanus toxoids.
Englund JA; Anderson EL; Reed GF; Decker MD; Edwards KM; Pichichero ME; Steinhoff MC; Rennels MB; Deforest A; Meade BD
Pediatrics; 1995 Sep; 96(3 Pt 2):580-4. PubMed ID: 7659480
[TBL] [Abstract][Full Text] [Related]
7. Effect of injection site on reactogenicity and immunogenicity of acellular and whole-cell pertussis component diphtheria-tetanus-pertussis vaccines in infants.
Tapiainen T; Cherry JD; Heininger U
Vaccine; 2005 Oct; 23(43):5106-12. PubMed ID: 16023771
[TBL] [Abstract][Full Text] [Related]
8. Acellular pertussis vaccines: neutralization by immune sera of the lethality of pertussis toxin and viable Bordetella pertussis for chick embryos.
Calver GA
Biologicals; 1999 Jun; 27(2):143-7. PubMed ID: 10600203
[TBL] [Abstract][Full Text] [Related]
9. Acellular and whole-cell pertussis vaccines as booster doses: a multicenter study.
Englund JA; Decker MD; Edwards KM; Pichichero ME; Steinhoff MC; Anderson EL
Pediatrics; 1994 Jan; 93(1):37-43. PubMed ID: 8265321
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of a tetraplex microsphere assay for Bordetella pertussis antibodies.
Prince HE; Lapé-Nixon M; Matud J
Clin Vaccine Immunol; 2006 Feb; 13(2):266-70. PubMed ID: 16467336
[TBL] [Abstract][Full Text] [Related]
11. Serological responses to infection with B. pertussis.
Giammanco A; Taormina S; Genovese M; Mangiaracina G; Giammanco G; Chiarini A
Dev Biol Stand; 1997; 89():213-20. PubMed ID: 9272353
[TBL] [Abstract][Full Text] [Related]
12. Antibody responses and persistence in the two years after immunization with two acellular vaccines and one whole-cell vaccine against pertussis.
Giuliano M; Mastrantonio P; Giammanco A; Piscitelli A; Salmaso S; Wassilak SG
J Pediatr; 1998 Jun; 132(6):983-8. PubMed ID: 9627590
[TBL] [Abstract][Full Text] [Related]
13. Comparison of a three-component acellular pertussis vaccine with a whole-cell pertussis vaccine in 15- through 20-month-old infants.
Bernstein HH; Rothstein EP; Reisinger KS; Blatter MM; Arbeter AM; Fontana ME; Jacobs JM; Long SS; Rathfon H; Crayne O
Pediatrics; 1994 Apr; 93(4):656-9. PubMed ID: 8134224
[TBL] [Abstract][Full Text] [Related]
14. Serum IgG antibody responses to pertussis toxin and filamentous hemagglutinin in nonvaccinated and vaccinated children and adults with pertussis.
Trollfors B; Taranger J; LagergÄrd T; Sundh V; Bryla DA; Schneerson R; Robbins JB
Clin Infect Dis; 1999 Mar; 28(3):552-9. PubMed ID: 10194077
[TBL] [Abstract][Full Text] [Related]
15. Comparative biological activities of acellular pertussis vaccines produced by Kitasato.
Watanabe M; Izumiya K; Sato T; Yoshino K; Nakagawa N; Ohoishi M; Hoshino M
Kitasato Arch Exp Med; 1991 Apr; 64(1):31-42. PubMed ID: 1798236
[TBL] [Abstract][Full Text] [Related]
16. Levels of anti-pertussis antibodies related to protection after household exposure to Bordetella pertussis.
Storsaeter J; Hallander HO; Gustafsson L; Olin P
Vaccine; 1998 Dec; 16(20):1907-16. PubMed ID: 9796042
[TBL] [Abstract][Full Text] [Related]
17. Prevalence of pertussis antibodies in maternal delivery, cord, and infant serum.
Healy CM; Munoz FM; Rench MA; Halasa NB; Edwards KM; Baker CJ
J Infect Dis; 2004 Jul; 190(2):335-40. PubMed ID: 15216470
[TBL] [Abstract][Full Text] [Related]
18. Development and validation of a multiplex immunoassay for the simultaneous determination of serum antibodies to Bordetella pertussis, diphtheria and tetanus.
van Gageldonk PG; van Schaijk FG; van der Klis FR; Berbers GA
J Immunol Methods; 2008 Jun; 335(1-2):79-89. PubMed ID: 18407287
[TBL] [Abstract][Full Text] [Related]
19. Development of a guinea-pig model for potency/immunogenicity evaluation of diphtheria, tetanus acellular pertussis (DTaP) and Haemophilus influenzae type b polysaccharide conjugate vaccines.
Gupta RK; Anderson R; Cecchini D; Rost B; Griffin P; Benscoter K; Xu J; Montanez-Ortiz L; Siber GR
Dev Biol Stand; 1996; 86():283-96. PubMed ID: 8785957
[TBL] [Abstract][Full Text] [Related]
20. The Pertussis Serological Potency Test. Collaborative study to evaluatereplacement of the Mouse Protection Test.
van der Ark A; van Straaten-van de Kappelle I; Olander RM; Enssle K; Jadhav S; van de Donk H; Hendriksen C
Biologicals; 2000 Jun; 28(2):105-18. PubMed ID: 10885617
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]